{"id":"W4415725214","doi":"10.1002/art.43428","title":"Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial","year":2025,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Arthritis Society; National Institutes of Health; Cincinnati Children's Hospital Medical Center; Sanofi; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Tofacitinib; Juvenile; Clinical trial; Randomized controlled trial; Janus kinase inhibitor; Phase (matter)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003491373,0.001626907,0.003272289,0.0003878313,0.0007276624,0.001415177,0.0007876798,0.002444966,0.005420446],"category_scores_gemma":[0.002492096,0.0004955697,0.002475705,0.0004421772,0.0009643395,0.0009970531,0.0003218935,0.002949831,0.0006945592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007423228,"about_ca_system_score_gemma":0.001682609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007029434,"about_ca_topic_score_gemma":0.001849148,"domain_scores_codex":[0.9987918,0.0006948589,0.00008864276,0.0001463984,0.0001259776,0.0001525184],"domain_scores_gemma":[0.998786,0.0003085436,0.0003898846,0.00008519197,0.0001140673,0.0003162333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9648286,0.005702043,0.0007058172,0.001312374,0.001270415,0.00007947149,0.0000712066,0.0002715281,0.003133808,0.0001210974,0.001821911,0.02068158],"study_design_scores_gemma":[0.9755633,0.02205614,0.001138474,0.00003936327,0.0002633365,0.00003510792,0.000009461088,0.0002216558,0.000175749,0.00007441545,0.0004139202,0.000009064455],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9652084,0.01531211,0.001321474,0.001925968,0.001052822,0.008963052,0.002751305,0.0002991064,0.003165818],"genre_scores_gemma":[0.9738597,0.005664149,0.002117634,0.002551989,0.0008924931,0.01047111,0.001903677,0.00004123616,0.002497946],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005420446,"threshold_uncertainty_score":0.01846439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02234279094405725,"score_gpt":0.328667897597464,"score_spread":0.3063251066534067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}